Common use of Test Result Dispute Clause in Contracts

Test Result Dispute. 9.2.1 In the event that a dispute arises between C*P and ORPHAN in the testing performed by C*P for the PRODUCTS, the resolution will proceed in stages. The first stage requires direct communication between analysts from both parties to determine that the methods of analysis are the same and are being executed in the same manner at both sites. Second, carefully controlled and split samples should be sent from one site to another in an attempt to reach agreement. Should there be a failure to achieve resolution, analysts from both parties will be required to meet to work through the analysis of a mutually agreeable sample. If these actions fail to achieve resolution, and only after these avenues have been exhausted, a qualified referee laboratory will be used to achieve resolution. This laboratory must be agreeable to both parties prior to use. The results from this referee laboratory will be used as final authority to determine responsibilities, but whatever the outcome, ORPHAN retains the right to determine product release status. Financial liability is determined in the Definitive Agreement.

Appears in 2 contracts

Samples: Xyrem Supply Agreement (Jazz Pharmaceuticals Inc), Technical Services Agreement (Jazz Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Test Result Dispute. 9.2.1 In the event that a dispute arises between C*P and ORPHAN CLIENT in the testing performed by C*P for the PRODUCTS, the resolution will proceed in stages. The first stage requires direct communication between analysts from both parties to determine that the methods of analysis are the same and are being executed in the same manner at both sites. Second, carefully controlled and split samples should be sent from one site to another in an attempt to reach agreement. Should there be a failure to achieve resolution, analysts from both parties will be required to meet to work through the analysis of a mutually agreeable sample. If these actions fail to achieve resolution, and only after these avenues have been exhausted, a qualified referee laboratory will be used to achieve resolution. This laboratory must be agreeable to both parties prior to use. The results from this referee laboratory will be used as final authority to determine responsibilities, but whatever the outcome, ORPHAN CLIENT retains the right to determine product release status. Financial liability is determined in the Definitive Agreement.

Appears in 2 contracts

Samples: Manufacturing and Packaging Agreement (Cephalon Inc), Manufacturing and Packaging Agreement (Cephalon Inc)

Test Result Dispute. 9.2.1 In the event that a dispute arises between C*P and ORPHAN POZEN in the testing performed by C*P for the PRODUCTS, the resolution will proceed in stages. The first stage requires direct communication between analysts from both parties to determine that the methods of analysis are the same and are being executed in the same manner at both sites. Second, carefully controlled and split samples should be sent from one site to another in an attempt to reach agreement. Should there be a failure to achieve resolution, analysts from both parties will be required to meet to work through the analysis of a mutually agreeable sample. If these actions fail to achieve resolution, and only after these avenues have been exhausted, a qualified referee laboratory will be used to achieve resolution. This laboratory must be agreeable to both parties prior to use. The results from this referee laboratory will be used as final authority to determine responsibilities, but whatever the outcome, ORPHAN POZEN retains the right to determine product release status. Financial liability is determined in the Definitive Agreement.

Appears in 1 contract

Samples: Supply Agreement (Pozen Inc /Nc)

AutoNDA by SimpleDocs

Test Result Dispute. 9.2.1 9.2.1. In the event that a dispute arises between C*P BAXTER and ORPHAN IDEC in the testing performed by C*P BAXTER for the PRODUCTSPRODUCT, the resolution will proceed in stages. The first stage requires direct communication between analysts Quality management from both parties to determine that the methods of analysis are the same and are being executed in the same manner at both the applicable sites. Second, carefully controlled and split samples should be sent from one site to another in an attempt to reach agreement. Should there be a failure to achieve resolution, analysts QC Management from both the parties will be required to meet to work through the analysis of a mutually agreeable sample. If these actions fail to achieve resolution, and only after these avenues have been exhausted, a qualified referee laboratory will be used to achieve resolution. This laboratory must be agreeable to both parties prior to use. The results from this referee laboratory will be used as final authority to determine responsibilities, but whatever the outcome, ORPHAN IDEC retains the right to determine product release status. Financial liability is determined in the Definitive Supply Agreement.

Appears in 1 contract

Samples: Commercial Supply Agreement (Idec Pharmaceuticals Corp / De)

Time is Money Join Law Insider Premium to draft better contracts faster.